Reported Oct 28, 2026 · Ongoing
Brevital Sodium (methohexital sodium), 500 mg/vial, Rx only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY…
Par Health USA, LLC
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Par Health USA, LLC · 870 Parkdale Rd · Rochester, MI · 48307-1740
Is this the product you have?
- Brevital Sodium (methohexital sodium), 500 mg/vial, Rx only
- Distributed byPar Pharmaceutical, Chestnut Ridge, NY 10977
- NDC42023-105-01
- Lot codes and dates
- Lot
86930Exp. 02/202888623Exp. 04/2028
- Lot
- Amount recalled
- 20,567 vials
This recall covers 2 products
The agency filed one notice per product. You are reading one of them; the other one is below.
Where it was sold
- Nationwide
Why it was recalled
Presence of Particulate Matter
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Par Health USA, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.